九九在线视屏免费_99热这里只有精品国产免费观看_欧美日韩综合国产亚洲精品区_亚洲国产精品成人_天美资源传媒app_91在线视频免费看_最新好看电影免费观看_自拍偷拍 另类小说_亚洲AV永久无码无人区电影_国产精品永久在线播放

新聞動態

以規范促管理,以管理促效益 以效益促創新,以創新求發展。
您的當前位置:首頁 > Innovate > Scientific research achievements

Scientific research achievements

To undertake national projects and scientific research projects and achievements of governments at all levels



The company has undertaken 24 national, provincial, Jinan City and high-tech zone research projects; the company has been rated as one of the top 10 independent innovation enterprises in Shandong Province with its abundant scientific research achievements; the first class new drug project has won the excellent award of China Innovation and entrepreneurship competition, which is one of the only two award-winning enterprises in the field of biomedicine; it has won the innovation competition action plan of small and medium-sized enterprises (biomedicine) in Shandong Province The project "research and development of a new biological product for nasopharyngeal carcinoma, Clostridium gloeosporioides spore lyophilized powder", won the first prize of the national energy chemical geological system outstanding staff technical innovation achievements; one employee won the Shandong Province May 1st Labor Medal; 2 employees won the Shandong Province pharmaceutical and chemical industry system and Jinan City May 1st Labor Medal; won the influence of Jinan science and technology Figure 1; Gao One of the most beautiful science and technology workers in the new area.

Display of some intellectual property rights




Plan and arrangement of transformation of scientific and technological achievements



1、 Core product: biological class 1 new drug "Clostridium gloeosporioides spore lyophilized powder for injection" (national and Shandong provincial major new drug development special project), obtained the approval of clinical trial in 2020, completed the clinical trial in 3 years, and applied for the new drug certificate.
2、 The diagnostic kit for Alzheimer's disease is undergoing clinical trials and preparing to apply for medical device certificate.
3、Padi2 and PADI4 multiple ELISA kits for early tumor diagnosis are undergoing clinical trials and preparing to apply for medical device certificate。
4、Tumor cell therapy: innovative multiple cells (NK, DC, car-t, CTL, etc.) for the treatment of tumor have been very mature, and can be used in clinical experimental research.
5、Stem cells and regenerative medicine: the research on stem cells (autologous adipose derived mesenchymal stem cells and umbilical cord mesenchymal stem cells) in the treatment of various diseases has been very mature. Many batches of products have been prepared and frozen, and transferred to scientific research institutions for clinical research and research application research.

Rapid development



Main research directions



Innovative drug research and development 90%: bacterial therapy for cancer, cell therapy for cancer
Basic R & D 10%: new drug research, diagnostic kits, etc


Copyright ? 2020 山東新創生物科技有限公司 版權所有 All Rights Reserved